The Role of the Liquid Biopsy in Decision-Making for Patients with Non-Small Cell Lung Cancer

Por D. Akhoundova, J. Mosquera Martinez, L. E. Musmann, C. Britschgi, C. Rütsche, M. Rechsteiner, E. Nadal, M. R. Garcia Campelo, A. Curioni-Fontecedro
Publicado em 2020-11-01

In vitro biochemical and in vivo biological studies of the uridine 'rescue' of 5-fluorouracil.

Por Peters, G. J., van Dijk, J., Laurensse, E., van Groeningen, C. J., Lankelma, J., Leyva, A., Nadal, J. C., Pinedo, H. M.
Publicado em 1988

P14.08 Neurological complications of emerging targeted therapies

Por Jaramillo-Jiménez, E., Simó, M., Gil-Gil, M. J., Majós, C., Nadal, E., Piulats, J. M., Bruna, J.
Publicado no Neuro Oncol (2016)

Fasting plasma glucose is an independent predictor of survival in patients with locally advanced non-small cell lung cancer treated with concurrent chemoradiotherapy

Por Bergamino, Milana, Rullan, Antonio J., Saigí, Maria, Peiró, Inmaculada, Montanya, Eduard, Palmero, Ramón, Ruffinelli, José Carlos, Navarro, Arturo, Arnaiz, María Dolores, Brao, Isabel, Aso, Samantha, Padrones, Susana, Cardenal, Felipe, Nadal, Ernest
Publicado no BMC Cancer (2019)

Fasting plasma glucose is an independent predictor of survival in patients with locally advanced non-small cell lung cancer treated with concurrent chemoradiotherapy

Por Milana Bergamino, Antonio J. Rullan, Maria Saigí, Inmaculada Peiró, Eduard Montanya, Ramón Palmero, José Carlos Ruffinelli, Arturo Navarro, María Dolores Arnaiz, Isabel Brao, Samantha Aso, Susana Padrones, Felipe Cardenal, Ernest Nadal
Publicado em 2019-02-01

Geriatric assessment may help decision-making in elderly patients with inoperable, locally advanced non-small-cell lung cancer

Por Antonio, Maite, Saldaña, Juana, Linares, Jennifer, Ruffinelli, José C, Palmero, Ramón, Navarro, Arturo, Arnaiz, Maria Dolores, Brao, Isabel, Aso, Samantha, Padrones, Susana, Navarro, Valentí, González-Barboteo, Jesús, Borràs, Josep Maria, Cardenal, Felipe, Nadal, Ernest
Publicado no Br J Cancer (2018)

Dual MET and ERBB inhibition overcomes intratumor plasticity in osimertinib-resistant-advanced non-small-cell lung cancer (NSCLC)

Por Martinez-Marti, A, Felip, E, Matito, J, Mereu, E, Navarro, A, Cedrés, S, Pardo, N, Martinez de Castro, A, Remon, J, Miquel, J M, Guillaumet-Adkins, A, Nadal, E, Rodriguez-Esteban, G, Arqués, O, Fasani, R, Nuciforo, P, Heyn, H, Villanueva, A, Palmer, H G, Vivancos, A
Publicado no Ann Oncol (2017)

Combination of KIR2DS4 and FcγRIIa polymorphisms predicts the response to cetuximab in KRAS mutant metastatic colorectal cancer

Por Borrero-Palacios, A., Cebrián, A., Gómez del Pulgar, M. T., García-Carbonero, R., Garcia-Alfonso, P., Aranda, E., Elez, E., López-López, R., Cervantes, A., Valladares, M., Nadal, C., Viéitez, J. M., Guillén-Ponce, C., Rodríguez, J., Hernández, I., García, J. L., Vega-Bravo, R., Puime-Otin, A., Martínez-Useros, J., Del Puerto-Nevado, L., Rincón, R., Rodríguez-Remírez, M., Rojo, F., García-Foncillas, J.
Publicado no Sci Rep (2019)